Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 952
Gene Symbol: CD38
CD38
0.080 Biomarker phenotype BEFREE These data suggest that 211At-CD38 offers the potential to eliminate residual MM cell clones in low-disease-burden settings, including MRD. 31395601 2019
Entrez Id: 952
Gene Symbol: CD38
CD38
0.080 Biomarker phenotype BEFREE We studied the CD34+CD38-CD123+ fraction in AML blasts at diagnosis, and its utility as a unique phenotype for minimal residual disease (MRD) of AML patients. 29065396 2018
Entrez Id: 952
Gene Symbol: CD38
CD38
0.080 Biomarker phenotype BEFREE In this study, we evaluated 86 pediatric patients with both diagnostic and remission flow cytometry studies and compared expression of CD81, CD58, CD19, CD34, CD20, and CD38 in the detection of MRD. 29500862 2018
Entrez Id: 952
Gene Symbol: CD38
CD38
0.080 Biomarker phenotype BEFREE The consensus on best practice for detection of MRD in MM is that CD38, CD138, and CD45 are analyzed in combination with CD19, CD56, CD27, CD81, and CD117. 25907102 2016
Entrez Id: 952
Gene Symbol: CD38
CD38
0.080 GeneticVariation phenotype BEFREE Among the presenting features, certain 11q23 abnormalities, such as t(6;11) and t(10;11), acute megakaryoblastic leukaemia without the t(1;22), and age ≥10 years were associated with inferior outcome in patients who had MRD-negative status after either remission induction I or II. 25164427 2015
Entrez Id: 952
Gene Symbol: CD38
CD38
0.080 Biomarker phenotype BEFREE The aim of this study was to determine the prognostic power of minimal residual disease (MRD) measured by fluorescence in situ hybridization (FISH) in CD34(+)CD38(-) cells sorted by flow cytometry at different periods during therapy. 24844781 2014
Entrez Id: 952
Gene Symbol: CD38
CD38
0.080 AlteredExpression phenotype BEFREE In this study we aimed to assess the value of real-time polymerase chain reaction (RT-PCR) for detecting the immunoglobulin heavy chain (IgH) gene rearrangement using allele-specific molecular beacons as fluorescence probes to quantify minimal residual disease (MRD) and also to correlate post-treatment flow cytometric detection of plasma cells' (PCs) expression of CD19, CD38, CD45, CD56 and CD138 in MM. 23818359 2013
Entrez Id: 952
Gene Symbol: CD38
CD38
0.080 AlteredExpression phenotype BEFREE Both high ZAP-70 and increased CD38 expression predict failure to obtain MRD-negative response. 18172266 2008